NCT07310784 2026-03-03
A Phase II Trial of LM103 in Advanced Melanoma
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase 2 Recruiting
Suzhou BlueHorse Therapeutics Co., Ltd.
Swiss Cancer Institute
Shanghai Juncell Therapeutics
National Medical Research Radiological Centre of the Ministry of Health of Russia
University of Miami
Memorial Sloan Kettering Cancer Center
Sarcoma Oncology Research Center, LLC